These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 805001)

  • 1. Lymphocyte-mediated cytotoxicity against tumor cells. I. Con A activated cytotoxic effector cells exhibit immunological specificity.
    Waterfield JD; Waterfield EM; Möller G
    Cell Immunol; 1975 Jun; 17(2):392-404. PubMed ID: 805001
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of lymphocyte-mediated cytotoxicity against allogeneic tumor cells by concanavalin A in vivo.
    Anaclerio A; Waterfield JD; Möller G
    J Immunol; 1974 Sep; 113(3):870-5. PubMed ID: 4413847
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell-mediated immune responses in vitro. I. Suppression of the generation of cytotoxic lymphocytes by concanavalin A and concanavalin A-activated spleen cells.
    Peavy DL; Pierce CW
    J Exp Med; 1974 Aug; 140(2):356-69. PubMed ID: 4276949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inability of normal and activated thymus-derived cells to act as cytotoxic effector cells against antibody-coated targets.
    Forman J; Britton S; Möller G
    Transplantation; 1976 Oct; 22(4):374-9. PubMed ID: 136072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated immune reaction against tumors induced by oncornaviruses. 3. Studies by mixed lymphocyte-tumor reaction.
    Senik A; Gomard E; Plata F; Levy JP
    Int J Cancer; 1973 Jul; 12(1):233-41. PubMed ID: 4133585
    [No Abstract]   [Full Text] [Related]  

  • 6. Lymphocyte-mediated cytolysis of allogeneic tumor cells in vitro. I. Search for target antigens in subcellular fractions.
    Todd RF; Stulting RD; Amos DB
    Cell Immunol; 1975 Aug; 18(2):304-23. PubMed ID: 806359
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytotoxic potential of mouse spleen cells on H-2 antibody-treated target cells.
    Kiessling R; Klein E
    J Exp Med; 1973 Feb; 137(2):527-32. PubMed ID: 4631140
    [No Abstract]   [Full Text] [Related]  

  • 8. Cell-mediated reaction against tumors induced by oncornaviruses. I. Kinetics and specificity of the immune response in murine sarcoma virus (MSV)-induced tumors and transplanted lymphomas.
    Leclerc JC; Gomard E; Levy JP
    Int J Cancer; 1972 Nov; 10(3):589-601. PubMed ID: 4128690
    [No Abstract]   [Full Text] [Related]  

  • 9. Suppressed development of cytotoxic lymphoid cells in tumor-immunized mice.
    Martin WJ; Wunderlich JR; Macdonald J
    Isr J Med Sci; 1973 Mar; 9(3):324-31. PubMed ID: 4710040
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro cytotoxicity by a nonthymus-processed lymphocyte population with specificity for a virally determined tumor cell surface antigen.
    Lamon EW; Skurzak HM; Klein E; Wigzell H
    J Exp Med; 1972 Nov; 136(5):1072-9. PubMed ID: 4117188
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell-mediated cytotoxicity against ectromelia virus-infected target cells. I. Specificity and kinetics.
    Gardner I; Bowern NA; Blanden RV
    Eur J Immunol; 1974 Feb; 4(2):63-7. PubMed ID: 4211857
    [No Abstract]   [Full Text] [Related]  

  • 12. Some characteristics of the antibody-induced cell-mediated cytotoxicity against leukemia cells.
    Britton S; Forman J
    Transplantation; 1974 Feb; 17(2):180-7. PubMed ID: 4590289
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell-mediated immunity to Friend virus-induced leukemia.
    Ting CC; Shiu G; Rodrigues D; Herberman RB
    Cancer Res; 1974 Jul; 34(7):1684-7. PubMed ID: 4134674
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system.
    Harada M; Pearson G; Redmon L; Winters E; Kasuga S
    J Immunol; 1975 Apr; 114(4):1318-22. PubMed ID: 1090675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated membrane antigens and the antitumor immune reactions.
    Levy JP; Kourilsky FM
    Transplant Proc; 1973 Dec; 5(4):1435-40. PubMed ID: 4130056
    [No Abstract]   [Full Text] [Related]  

  • 16. The immune response to primary Moloney sarcoma virus tumors in BALB-c mice: cellular and humoral activity of long-term regressors.
    Lamon EW; Anderson B; Wigzell H; Fenyö EM; Klein E
    Int J Cancer; 1974 Jan; 13(1):91-104. PubMed ID: 4594340
    [No Abstract]   [Full Text] [Related]  

  • 17. Generation of cytotoxic lymphocytes in mixed lymphocyte reactions. I. Specificity of the effector cells.
    Forman J; Möller G
    J Exp Med; 1973 Sep; 138(3):672-85. PubMed ID: 4269560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte-mediated cytotoxicity against allogeneic tumour cells. IV. Fine specificity mapping and characterization of concanavalin A-activated cytotoxic effector lymphocytes.
    Waterfield JD; Nixon DF; Mair MG
    Immunology; 1981 Dec; 44(4):685-93. PubMed ID: 6797935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of the effector cells mediating cytotoxicity against antibody-coated target cells. I. Phagocytic and non-phagocytic effector cell activity against erythrocyte and tumour target cells in a 51Cr release cytotoxicity assay and [125I]IUdR growth inhibition assay.
    Greenberg AH; Shen L; Medley G
    Immunology; 1975 Oct; 29(4):719-29. PubMed ID: 810417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of terminal complement components to induce lysis of Moloney virus transformed lymphocytes.
    Cooper NR; Polley MJ; Oldstone MB
    J Immunol; 1974 Feb; 112(2):866-8. PubMed ID: 4855965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.